CardioneuROablation for Reflex Syncope: Effects on autonoMic cArdiac Regulation and Efficacy Assessment - the Roman Syncope Study.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 48
- 试验地点
- 2
- 主要终点
- Time to first syncope recurrence.
研究概览
简要总结
Aim. To assess the effects of cardioneuroablation (CNA) on cardiac autonomic regulation and syncope recurrences in patients with vasovagal syncope (VVS), and to compare this novel approach with standard non-pharmacological treatment.
Measurements.
-
Before CNA:
-
Detailed history taking and assessment of eligibility
-
Baseline 12-lead ECG for heart rate assessment, morphology and duration of the P wave and PR interval
-
24-hour Holter ECG for heart rhythm (mean, minimal, maximal, pauses) and heart rate variability (HRV) assessment
-
Passive tilt test (70 degrees, 45 minutes) to fulfill inclusion criterion and to assess baseline autonomic parameters such as HRV and baroreflex sensitivity (BRS) using sequential method. These parameters will be calculated from 5 min recordings before and after orthostatic stress (tilt).
-
Atropine test - positive response to intravenous atropine in a dose of 2 mg defined as at least 30% increase in sinus rate compared with baseline value
-
Assessment of quality of life using the SF-36 questionnaire
-
Implantable Loop Recorder (ILR) implantation 2-3 days before CNA
-
During CNA:
-
Heart rate before and immediately after CNA
-
Episodes of bradycardia (sinus arrest or atrio-ventricular block) during application of RF to GP.
-
Standard electrophysiological parameters (sinus node recovery time, corrected sinus recovery time, refractory atrio-ventricular node, atrio-ventricular conduction - Wenckebach point, A-H and H-V intervals) will be assessed before an immediately after CNA
-
Atropine test (2 mg) will be repeated immediately after CNA.
-
After CNA:
-
1-2 days after CNA standard ECG
-
Follow-up: 3, 12 and 24 months after CNA assessment of symptoms, 12 lead standard ECG, control of ILR, 24-hour Holter ECG, tilt test and atropine test will be performed. Additionally, quality of life will be assessed using SF-36 questionnaire
Anticipated results.
- CNA performed with technique used in the present study is effective in > 90% of patients.
- CNA-induced changes in analysed ECG and autonomic parameters predict CNA efficacy
详细描述
Introduction.
Reflex syncope due to vasovagal reaction is the most frequent cause of transient loss of consciousness (TLOC) in general population. [1-4] It markedly decreases quality of life and may lead to injury. [5, 6] The mechanism of vasovagal syncope (VVS) is complex. One of the most important mechanisms is enhanced parasympathetic activity triggered by abnormal mechanoreceptor reflex and other mechanisms. This leads to prolonged asystole and/or vasodilatation, resulting in syncope. [7] Treatment of VVS remains a challenge. Non-pharmacological treatment such as fluid and salt intake, avoiding situations triggering syncope or tilt training is not effective in a significant proportion of subjects with syncope. Pharmacotherapy is even less effective. Syncope recurs in 25-65% of patients. Alternative therapy, especially in patients with prolonged asystole, is pacemaker implantation, recommended by the guidelines in patients aged > 40 years with documented spontaneous cardioinhibitory VVS and severe symptoms. However, permanent pacing occurs ineffective in at least 25% of patients. In addition, VVS occurs predominantly in young persons in whom permanent pacing should be avoided as much as possible. [8-13] Thus, the need for new treatment options in VVS is clear.
Ablation for atrial fibrillation (AF) has been successfully performed for almost two decades. Apart from pulmonary vein isolation which is a corner stone of AF ablation, autonomic control of the heart is modified by ablation of ganglionated plexi (GP). It has been well documented that in some patients GP ablation increases the success rate of ablation, especially in patients with vagally-mediated AF. Thus, the technique of GP ablation, mainly using the radio-frequency energy, is well established and safe.
Based on data coming from GP ablation during AF procedures, this method has been recently proposed for patients with VVS. The postulated beneficial mechanisms of GP ablation in VVS are attenuation of parasympathetic activity, leading to elimination or reduction reflex asystole and bradycardia. To date, a few case series consisting of up to 70 patients demonstrated very promising results. [15-18]. However, this experience is limited to a few centers. Also, the optimal methodology of the procedure, called cardioneuroablation (CNA) or cardioneuromodulation, is not known. There is no consensus yet as to how many GP's, in both atria or only in the right atrium, in which order and to what extent should be ablated. Moreover, mechanisms responsible for beneficial effects of CNA as well as methods assessing it's efficacy are not clear.
Aim. To assess the effects of CNA on cardiac autonomic regulation and syncope recurrences in patients with VVS, and to compare this novel approach with standard non-pharmacological treatment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •At least one documented spontaneous VVS during preceding 12 months or one syncope in history leading to injury and minimum 2 presyncopal events during preceding 12 months, refractory to all recommended types of standard treatment.
- •In case of lack of ECG documentation during spontaneous syncope and history suggesting reflex syncope, at least 3 seconds of asystole due to sinus arrest or atrio-ventricular block with syncope or bradycardia <40 beats per minute with syncope or presyncope during baseline tilt test
- •Sinus rhythm during ECG and tilt test
- •Significantly decreased quality of life due to syncope
- •Positive response to atropine test
- •Obtained written informed consent.
排除标准
- •Other possible and treatable causes of syncope such as significant cardiac disease, cardiac arrhythmia or abnormalities of vertebro-basiliar arteries
- •History of stroke or TIA
- •History of cardiac surgery
- •Contraindications to ablation in the right or left atrium
结局指标
主要结局
Time to first syncope recurrence.
时间窗: Two-year follow-up after starting treatment.
Recurrence of syncope (in days) after using the appropriate method (cardioneuroablation or standard non-pharmacological treatment).
次要结局
- Syncope burden.(Two-year follow-up after starting treatment.)
- Presyncope burden.(Two-year follow-up.)
- Cardioneuroablation-induced changes in baroreflex sensitivity predicting ablation efficacy.(Two-year follow-up.)
- Cardioneuroablation-induced changes in heart rate variability predicting ablation efficacy.(3, 12 and 24 months after cardioneuroablation.)
- Heart rate and atrio-ventricular conduction if syncope occurs.(Two-year follow-up.)
- Complications associated with CNA procedure(Two-year follow-up.)
研究者
Prof. Piotr Kulakowski
Principal Investigator
Centre of Postgraduate Medical Education
